Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • Hardware (& Manufacturing) |
Stages | Expansion, MBO/LBO,Acquisition |
Investing | Italy • China • Europe |
Investment Range | €10,000,000 - €30,000,000 |
Assets Under Management | €3,270,750,000 |
Mandarin Capital Partners is an international private equity fund focusing on investments in mid-market European companies with a strong export orientation and significant market potential, particularly in China and Europe. The firm was established in 2007 and has a strategy rooted in assisting European enterprises to expand their businesses into the Chinese market. Mandarin Capital Partners specializes in equity investments, with a preference for acquiring a controlling or minority stake in companies that demonstrate strong growth prospects, either through organic development or buy-and-build strategies. With a proficiency in Expansion, MBO/LBO, and Acquisition, they seek to not only invest but also impart their expertise in facilitating cross-border growth. The fund has an investment range between €10 million and €30 million and manages assets worth approximately €3.27 billion. Headquartered in Milan, Italy, with the main office located at Corso di Porta Nuova 3, the firm leverages its deep understanding of the European and Chinese markets to aid portfolio companies in identifying customer opportunities, forging strategic alliances, and executing greenfield investments, while also aiding in personnel selection to support international endeavors. Their aim is to create a symbiotic relationship where European businesses can thrive in the expansive Chinese market, thereby generating substantial returns on investments and fostering global economic integration between the two regions.